Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma-Reply

被引：0
|
作者：
Mastrolonardo, Eric V. [1 ]
Llerena, Pablo [1 ]
Curry, Joseph M. [1 ]
机构：
[1] Thomas Jefferson Univ Hosp, Dept Otolaryngol Head & Neck Surg, 925 Chestnut St,6th Floor, Philadelphia, PA 1107 USA
来源：
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY | 2025年 / 151卷 / 02期
关键词：
D O I：
10.1001/jamaoto.2024.3965
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
    Manukian, Gregor
    Bar-Ad, Voichita
    Lu, Bo
    Argiris, Athanassios
    Johnson, Jennifer M.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [22] Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI).
    Alfieri, Salvatore
    Ferrara, Roberto
    Calareso, Giuseppina
    Cavalieri, Stefano
    Platini, Francesca
    Mancinelli, Moela
    Resteghini, Carlo
    Orlandi, Ester
    Iacovelli, Nicola Alessandro
    Ferella, Letizia
    Piazza, Cesare
    Apollonio, Giulia
    Galbiati, Donata
    Bossi, Paolo
    Bergamini, Cristiana
    Locati, Laura Deborah
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.
    Even, Caroline
    Martin, Nicolas
    Borcoman, Edith
    Auperin, Anne
    Torossian, Nouritza
    Baste, Neus
    Guigay, Joel
    Le Tourneau, Christophe
    Saada, Esma
    Daste, Amaury
    Saleh, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy
    Scarini, Joao Figueira
    Lavareze, Luccas
    de Lima-Souza, Reydson Alcides
    Emerick, Carolina
    Goncalves, Mayara Trevizol
    Figueiredo-Maciel, Tayna
    Vieira, Gustavo de Souza
    Kimura, Talita de Carvalho
    de Sa, Raisa Sales
    Aquino, Iara Goncalves
    Fernandes, Patricia Maria
    Kowalski, Luiz Paulo
    Altemani, Albina
    Mariano, Fernanda Viviane
    Abu Egal, Erika Said
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180
  • [25] Incidence of hypothyroidism in head and neck squamous cell carcinoma patients receiving radiotherapy with and without immune checkpoint inhibitors.
    Leddon, Jennifer
    Chirra, Martina
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Combination therapy with immune checkpoint inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: A meta-analysis
    Chen, Long
    Mo, Dun-Chang
    Hu, Min
    He, Wei
    Yang, Qiang-Wei
    Tang, Jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [27] Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma
    Bila, Michel
    Franken, Amelie
    Van Dessel, Jeroen
    Garip, Melisa
    Meulemans, Jeroen
    Willaert, Robin
    Hoeben, Ann
    Vander Poorten, Vincent
    Clement, Paul M.
    ORAL ONCOLOGY, 2024, 149
  • [28] Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials
    Poulose, Jissy Vijo
    Kainickal, Cessal Thommachan
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (05): : 388 - 411
  • [29] Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors
    Kim, Dong Hyun
    Kang, Mingu
    Park, Gahee
    Mostafavi, Mohammad
    Lim, Yoojoo
    Ock, Chan-Young
    Koh, Jiwon
    Jeon, Yoon Kyung
    Jung, Kyeong Cheon
    Ahn, Soon-Hyun
    Chung, Eun-Jae
    Kwon, Seong-Keun
    Keam, Bhumsuk
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [30] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with squamous cell carcinoma of the head and neck.
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada, Esma
    Even, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345